Global Gene Therapy for CNS Disorders Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14088624 | Publishing Date : 12-Apr-2019 | No. of pages : 96
Detailed TOC of Global Gene Therapy for CNS Disorders Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type (2014-2025)
1.4.2 Ex Vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy for CNS Disorders Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gene Therapy for CNS Disorders Market Size
2.2 Gene Therapy for CNS Disorders Growth Trends by Regions
2.2.1 Gene Therapy for CNS Disorders Market Size by Regions (2014-2025)
2.2.2 Gene Therapy for CNS Disorders Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Gene Therapy for CNS Disorders Market Size by Manufacturers
3.1.1 Global Gene Therapy for CNS Disorders Revenue by Manufacturers (2014-2019)
3.1.2 Global Gene Therapy for CNS Disorders Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gene Therapy for CNS Disorders Market Concentration Ratio (CR5 and HHI)
3.2 Gene Therapy for CNS Disorders Key Players Head office and Area Served
3.3 Key Players Gene Therapy for CNS Disorders Product/Solution/Service
3.4 Date of Enter into Gene Therapy for CNS Disorders Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gene Therapy for CNS Disorders Market Size by Type (2014-2019)
4.2 Global Gene Therapy for CNS Disorders Market Size by Application (2014-2019)
5 United States
5.1 United States Gene Therapy for CNS Disorders Market Size (2014-2019)
5.2 Gene Therapy for CNS Disorders Key Players in United States
5.3 United States Gene Therapy for CNS Disorders Market Size by Type
5.4 United States Gene Therapy for CNS Disorders Market Size by Application
6 Europe
6.1 Europe Gene Therapy for CNS Disorders Market Size (2014-2019)
6.2 Gene Therapy for CNS Disorders Key Players in Europe
6.3 Europe Gene Therapy for CNS Disorders Market Size by Type
6.4 Europe Gene Therapy for CNS Disorders Market Size by Application
7 China
7.1 China Gene Therapy for CNS Disorders Market Size (2014-2019)
7.2 Gene Therapy for CNS Disorders Key Players in China
7.3 China Gene Therapy for CNS Disorders Market Size by Type
7.4 China Gene Therapy for CNS Disorders Market Size by Application
8 Japan
8.1 Japan Gene Therapy for CNS Disorders Market Size (2014-2019)
8.2 Gene Therapy for CNS Disorders Key Players in Japan
8.3 Japan Gene Therapy for CNS Disorders Market Size by Type
8.4 Japan Gene Therapy for CNS Disorders Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gene Therapy for CNS Disorders Market Size (2014-2019)
9.2 Gene Therapy for CNS Disorders Key Players in Southeast Asia
9.3 Southeast Asia Gene Therapy for CNS Disorders Market Size by Type
9.4 Southeast Asia Gene Therapy for CNS Disorders Market Size by Application
10 India
10.1 India Gene Therapy for CNS Disorders Market Size (2014-2019)
10.2 Gene Therapy for CNS Disorders Key Players in India
10.3 India Gene Therapy for CNS Disorders Market Size by Type
10.4 India Gene Therapy for CNS Disorders Market Size by Application
11 Central & South America
11.1 Central & South America Gene Therapy for CNS Disorders Market Size (2014-2019)
11.2 Gene Therapy for CNS Disorders Key Players in Central & South America
11.3 Central & South America Gene Therapy for CNS Disorders Market Size by Type
11.4 Central & South America Gene Therapy for CNS Disorders Market Size by Application
12 International Players Profiles
12.1 Gilead (Kite Pharma)
12.1.1 Gilead (Kite Pharma) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Therapy for CNS Disorders Introduction
12.1.4 Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2014-2019)
12.1.5 Gilead (Kite Pharma) Recent Development
12.2 Amgen (BioVex)
12.2.1 Amgen (BioVex) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Therapy for CNS Disorders Introduction
12.2.4 Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2014-2019)
12.2.5 Amgen (BioVex) Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Therapy for CNS Disorders Introduction
12.3.4 Novartis Revenue in Gene Therapy for CNS Disorders Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Roche (Spark Therapeutics)
12.4.1 Roche (Spark Therapeutics) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Therapy for CNS Disorders Introduction
12.4.4 Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2014-2019)
12.4.5 Roche (Spark Therapeutics) Recent Development
12.5 Bluebird Bio
12.5.1 Bluebird Bio Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gene Therapy for CNS Disorders Introduction
12.5.4 Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2014-2019)
12.5.5 Bluebird Bio Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Gene Therapy for CNS Disorders Market Size, Status and Forecast 2019-2025
List of Tables and FiguresTable Gene Therapy for CNS Disorders Key Market Segments
Table Key Players Gene Therapy for CNS Disorders Covered
Table Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gene Therapy for CNS Disorders Market Size Market Share by Type 2014-2025
Figure Ex Vivo Figures
Table Key Players of Ex Vivo
Figure In Vivo Figures
Table Key Players of In Vivo
Table Global Gene Therapy for CNS Disorders Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Gene Therapy for CNS Disorders Report Years Considered
Table Global Gene Therapy for CNS Disorders Market Size 2014-2025 (Million US$)
Figure Global Gene Therapy for CNS Disorders Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gene Therapy for CNS Disorders Market Size by Regions 2014-2025 (Million US$)
Table Global Gene Therapy for CNS Disorders Market Size by Regions 2014-2019 (Million US$)
Table Global Gene Therapy for CNS Disorders Market Share by Regions 2014-2019
Figure Global Gene Therapy for CNS Disorders Market Share by Regions 2014-2019
Figure Global Gene Therapy for CNS Disorders Market Share by Regions 2019
Table Market Top Trends
Table Global Gene Therapy for CNS Disorders Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gene Therapy for CNS Disorders Market Share by Manufacturers (2014-2019)
Figure Global Gene Therapy for CNS Disorders Market Share by Manufacturers in 2018
Table Global Gene Therapy for CNS Disorders Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gene Therapy for CNS Disorders Product/Solution/Service
Table Date of Enter into Gene Therapy for CNS Disorders Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$)
Table Global Gene Therapy for CNS Disorders Market Size Share by Type (2014-2019)
Figure Global Gene Therapy for CNS Disorders Market Size Market Share by Type (2014-2019)
Table Global Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$)
Table Global Gene Therapy for CNS Disorders Market Size Share by Application (2014-2019)
Figure Global Gene Therapy for CNS Disorders Market Size Market Share by Application (2014-2019)
Figure Global Gene Therapy for CNS Disorders Revenue Market Share by Application in 2018
Figure United States Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$)
Table United States Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$)
Table United States Key Players Gene Therapy for CNS Disorders Market Share (2018-2019)
Table United States Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$)
Table United States Gene Therapy for CNS Disorders Market Share by Type (2014-2019)
Table United States Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$)
Table United States Gene Therapy for CNS Disorders Market Share by Application (2014-2019)
Figure Europe Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$)
Table Europe Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$)
Table Europe Key Players Gene Therapy for CNS Disorders Market Share (2018-2019)
Table Europe Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$)
Table Europe Gene Therapy for CNS Disorders Market Share by Type (2014-2019)
Table Europe Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$)
Table Europe Gene Therapy for CNS Disorders Market Share by Application (2014-2019)
Figure China Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$)
Table China Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$)
Table China Key Players Gene Therapy for CNS Disorders Market Share (2018-2019)
Table China Gene Therapy for CNS Disorders Market Size by Type (2014-20189) (Million US$)
Table China Gene Therapy for CNS Disorders Market Share by Type (2014-2019)
Table China Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$)
Table China Gene Therapy for CNS Disorders Market Share by Application (2014-2019)
Figure Japan Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$)
Table Japan Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$)
Table Japan Key Players Gene Therapy for CNS Disorders Market Share (2018-2019)
Table Japan Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$)
Table Japan Gene Therapy for CNS Disorders Market Share by Type (2014-2019)
Table Japan Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$)
Table Japan Gene Therapy for CNS Disorders Market Share by Application (2014-2019)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gene Therapy for CNS Disorders Market Share (2018-2019)
Table Southeast Asia Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gene Therapy for CNS Disorders Market Share by Type (2014-2019)
Table Southeast Asia Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gene Therapy for CNS Disorders Market Share by Application (2014-2019)
Figure India Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$)
Table India Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$)
Table India Key Players Gene Therapy for CNS Disorders Market Share (2018-2019)
Table India Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$)
Table India Gene Therapy for CNS Disorders Market Share by Type (2014-2019)
Table India Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$)
Table India Gene Therapy for CNS Disorders Market Share by Application (2014-2019)
Figure Central & South America Gene Therapy for CNS Disorders Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gene Therapy for CNS Disorders Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gene Therapy for CNS Disorders Market Share (2018-2019)
Table Central & South America Gene Therapy for CNS Disorders Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gene Therapy for CNS Disorders Market Share by Type (2014-2019)
Table Central & South America Gene Therapy for CNS Disorders Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gene Therapy for CNS Disorders Market Share by Application (2014-2019)
Table Gilead (Kite Pharma) Company Details
Table Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2014-2019) (Million US$)
Figure Gilead (Kite Pharma) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2014-2019)
Table Gilead (Kite Pharma) Recent Development
Table Amgen (BioVex) Company Details
Table Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2014-2019)(Million US$)
Figure Amgen (BioVex) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2014-2019)
Table Amgen (BioVex) Recent Development
Table Novartis Company Details
Table Novartis Revenue in Gene Therapy for CNS Disorders Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2014-2019)
Table Novartis Recent Development
Table Roche (Spark Therapeutics) Company Details
Table Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2014-2019)(Million US$)
Figure Roche (Spark Therapeutics) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2014-2019)
Table Roche (Spark Therapeutics) Recent Development
Table Bluebird Bio Company Details
Table Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2014-2019)(Million US$)
Figure Bluebird Bio Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2014-2019)
Table Bluebird Bio Recent Development
Table Global Gene Therapy for CNS Disorders Market Size by Regions (Million US$) 2019-2025
Figure Global Gene Therapy for CNS Disorders Market Size Share by Regions (2019-2025)
Figure Global Gene Therapy for CNS Disorders Market Size Share by Regions in 2025
Figure United States Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD)
Figure China Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD)
Figure India Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gene Therapy for CNS Disorders Market Size Forecast (2019-2025)(Million USD)
Table Global Gene Therapy for CNS Disorders Market Size by Product (2019-2025) (Million US$)
Figure Global Gene Therapy for CNS Disorders Market Size by Product (2019-2025)
Figure Global Gene Therapy for CNS Disorders Market Size by Product in 2025
Table Global Gene Therapy for CNS Disorders Market Size by Application (2019-2025) (Million US$)
Figure Global Gene Therapy for CNS Disorders Market Size by Application (2019-2025)
Figure Global Gene Therapy for CNS Disorders Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Gene Therapy for CNS Disorders Market Size, Status and Forecast 2019-2025
Gilead (Kite Pharma)Amgen (BioVex)
Novartis
Roche (Spark Therapeutics)
Bluebird Bio